Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice

Circulation Research

Volumn 81, Issue 5, 1997, Pages 829-839

  Carmeliet, Peter ^a   Moons, Lieve ^a   Herbert, Jean Marc ^b   Crawley, James ^c   Lupu, Florea ^c   Lijnen, Roger ^a   Collen, Désiré ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b SANOFI   (France)

^c THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Blood vessel; Mouse; Neointima; Plasminogen activator; Restenosis

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTERY THROMBOSIS; ARTICLE; BLOOD VESSEL INJURY; CELL MIGRATION; FEMALE; INTIMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; THROMBOSIS; VASCULAR SMOOTH MUSCLE; WOUND HEALING;

EID: 0030696082     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.81.5.829     Document Type: Article

References (35)

1. van Leeuwen RTJ. Extracellular proteolysis and the migrating vascular smooth muscle cell. Fibrinolysis. 1996;10:59-74.
2. Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular disease. Circ Res. 1995;77:863-868.
3. Clowes AW, Reidy MA. Prevention if stenosis after vascular reconstruction: pharmacologic control of intimal hyperplasia: a review. J Vasc Surg. l991;13:885-891.
4. Reidy MA, Jackson D, Lindner V. Neointimal proliferation: control of vascular smooth muscle cell growth. Vasc Med Rev. 1992;3:156-167.
5. Libby P, Schwartz D, Brogi E, Tanaka H, Clinton SK. A cascade model for restenosis: a special case of atherosclerotic progression. Circulation. 1992;86(suppl III):III-47-III-52.
6. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA. Smooth myscle cell migration and matrix metallproteinase expression after arterial injury in the rat. Circ Res. 1994;75:539-545.
7. Clowes AW, Clowes MM, Au YPT, Reidy MA, Belin D. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res. 1990;67:61-67.
8. Jackson C, Reidy MA. The role of plasminogen activation in smooth muscle cell migration after injury. Ann N Y Acad Sci. 1992; 667:141-150.
9. Reidy MA, Irvin C, Lindner V. Migration of arterial wall cells: expression of plasminogen activators and inhibitors in injured rat arteries. Circ Res. 1996;78:405-414.
10. Fearns C, Samad F, Loskutoff DJ, van Hinsbergh VWM, ed. Vascular control of hemostasis. In: Vadas MA, Harlan J, series eds. Adnavces in Vascular Biology. London, UK: Harwood Academic Publishing; 1996:207-227.
11. Okada SS, Tomaszewski JE, Barnathan ES. Migrating vascular smooth muscle cells polarize cell surface urokinase receptors after injury in vitro. Exp Cell Res. 1995;217:180-187.
12. Collen D, Lijnen HR. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood. 1991;78:3114-3124.
13. Vassalli JD. The urokinase receptor. Fibrinolysis. 1994;8(suppl 1): 172-181.
14. Saksela O, Rifkin D. Cell-associated plasminogen activation: regulation and physiological function. Annu Rev Cell Biol 1988;4:93-126.
15. Carmeliet P, Collen D. Gene manipulation and transfer of the plasminogen system and coagulation system in mice. Semin Thromb Haemost 1990;22:525-542.
16. Romer J, Bugge TH, Pyke C, Loud LR, Flick MJ, Degen, Dano K. Impaired wound healing in mice with a disrupted plasminogen chain. Nat Med. 1990;2:287-292.
17. Bugge T, Kombrinck KW, Flick MJ, Daugherty CC, Danton MJ, Degen J. Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogcn deficiency. Cell. 1990;87:709-719.
18. Estreicher A, Müllhauser J, Carpentier GL, Orci L, Vassalli JD. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating nonocytes and promotes degradation of enzyme inhibitor complexes. J Cell Biol. 1990;111:783-792.
19. Reuning U, Bang N. Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens. Arterioscler Thromb. 1992;12:1161-1170.
20. Salame M, Martin W, More RS, Mahadeva H, deBono DP. Time sequence of changes in vessel wall tissue-type plasminogen activator, urokinase-type plasminogen activator and its receptor following experimental angioplasty, Fibrinolysis. 1996;10(suppl 3):249a. Abstract.
21. Kanthou C, Das S, Kakkar VV, Lupu F. Expression of some components of plasminogen activation (PA) pathway by arterial segments in organ culture after in vitro injury. Fibrinolysis. 1996;10(suppl 3):1la. Abstract.
22. Villaverde CA, Miralles M, Salvat N, Juan O, Tihau N, Pena E, Vigo P. Regulation of plasmin-generaling activity in human arteries, Fibrinolysis. 1996;10(suppl 3):148a. Abstract.
23. Carmetiet P, Moons L, Ploplis V, Plow EF, Collen D. Impaired arterial neointima formation in mice with disruption of the plasminogen gene. J Clin Invest. 1997;99:200-208.
24. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D, Mulligan RC. Physiological consequences of loss of plasminogen activator gene function in mice. Nature. 1994;368:419-423.
25. Carmeliet P, Moons L, Stassen JM, Van Vlaenderen I, Declercq C, Kockx M, Collen D. Vascular wound healing and neointima formation induced by perivascular injury in mice. Am J Pathol 1997;150:761-776.
26. Lindner V, Fineerle J, Reidy MA. Mouse model of arterial injury. Circ Res. 1993;73:792-790.
27. Declerck PJ, Carmeliet P, Verstreken M, De Cock F, Collen D. Generation of monoclonal antibodies against autologous proteins in gene-inactivated mice. J Biol Chem. 1995;270:8397-8400.
28. Lupu F, Heim DA, Bachmann F, Hurni M, Kakkar VV, Kruithof EKO. Plasminogen activator expression in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 1995;15:1444-1455.
29. Sato, Rifkin D. Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J Cell Biol. 1988;107:1199-1205.
30. Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest. 1983;49:208-215.
31. Ploplis V, French E, Carmeliet P, Collen D, Plow E. The plasminogen system and cell migration during an inflammatory response. Fibrinolysis. 1996;10(suppl 3):55. Abstract.
32. 3 binding to vitronectin. Nature. 1996;383: 441-443.
33. Dechend R, Mo S, Tamaschcke C, Schulz W, Gross M, Dietz R, Gulba D. Thrombin receptor and urokinase-type plasminogen activator are colocalized in vascular smooth muscle cells derived from human carotid atherosclerotic plaques. Fibrinolysis. 1996:10(suppl 3):254a. Abstract.
34. Padro T, Steins M, Li CX, Kienast J. Urokinase plasminogen activator (u-PA) in human atherosclerotic coronary arteries. Fibrinolysis, 1996;10(suppl-3):10a. Abstract.
35. Dano K, Behrendt N, Brünner N, Ellis V, Ploug M, Pyke C, The urokinase receptor: protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis. 1994;8(suppl 1): 189-203.